Berlim 25/10 association
Alternative Names: Berlim 25/10 association coated tabletLatest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator EMS
- Class Antihyperglycaemics; Antihyperlipidaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Dyslipidaemias; Type 2 diabetes mellitus
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for preclinical development in Dyslipidaemias in Brazil (PO, Tablet)
- 28 Nov 2024 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in Brazil (PO, Tablet)
- 26 Oct 2020 Preclinical trials in Dyslipidaemias in Brazil (PO) (Phase assumed)